SBLATTERO, DANIELE
 Distribuzione geografica
Continente #
NA - Nord America 11483
EU - Europa 4481
AS - Asia 711
Continente sconosciuto - Info sul continente non disponibili 22
SA - Sud America 6
AF - Africa 4
OC - Oceania 2
Totale 16709
Nazione #
US - Stati Uniti d'America 11459
PL - Polonia 979
SE - Svezia 933
UA - Ucraina 813
IT - Italia 659
CN - Cina 361
TR - Turchia 288
FI - Finlandia 272
BG - Bulgaria 166
IE - Irlanda 158
DE - Germania 149
GB - Regno Unito 135
FR - Francia 87
BE - Belgio 51
CA - Canada 24
VN - Vietnam 21
EU - Europa 20
HU - Ungheria 13
NL - Olanda 12
RU - Federazione Russa 12
JP - Giappone 7
RO - Romania 7
ES - Italia 6
GR - Grecia 6
BR - Brasile 5
CH - Svizzera 5
IN - India 5
IR - Iran 5
MY - Malesia 5
BD - Bangladesh 4
HR - Croazia 4
AT - Austria 3
NO - Norvegia 3
TN - Tunisia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
ID - Indonesia 2
IL - Israele 2
IQ - Iraq 2
LV - Lettonia 2
PK - Pakistan 2
TW - Taiwan 2
AU - Australia 1
CO - Colombia 1
DK - Danimarca 1
EE - Estonia 1
EG - Egitto 1
HK - Hong Kong 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MD - Moldavia 1
ME - Montenegro 1
MO - Macao, regione amministrativa speciale della Cina 1
NZ - Nuova Zelanda 1
SA - Arabia Saudita 1
SG - Singapore 1
SI - Slovenia 1
Totale 16709
Città #
Woodbridge 1578
Fairfield 1470
Ann Arbor 1377
Houston 1357
Warsaw 977
Chandler 946
Jacksonville 745
Wilmington 702
Ashburn 634
Seattle 622
Cambridge 496
Princeton 312
Izmir 279
Trieste 241
Sofia 165
Dublin 158
Beijing 119
Dearborn 85
Boardman 70
San Diego 70
Milan 59
Bremen 58
Brussels 51
Düsseldorf 43
Falls Church 43
Jinan 42
Des Moines 36
Nanjing 28
Norwalk 26
Buffalo 25
Sacile 24
Chicago 23
Hefei 23
Verona 21
Dong Ket 18
Kunming 17
Fremont 16
Helsinki 16
Shenyang 16
Denver 15
Guangzhou 15
Mestre 15
Redwood City 15
Phoenix 14
Toronto 13
Redmond 12
Budapest 10
San Francisco 9
Auburn Hills 8
Edinburgh 8
Kocaeli 8
Port Coquitlam 8
Torre Del Greco 8
Fuzhou 7
Hebei 7
London 7
Tulsa 7
Cascina 6
Detroit 6
Grafing 6
Leawood 6
Nanchang 6
Philadelphia 6
Andover 5
Boston 5
Changsha 5
Hangzhou 5
Taizhou 5
Tianjin 5
Wuhan 5
Zhengzhou 5
Chengdu 4
Chongqing 4
Frankfurt Am Main 4
Hamburg 4
Hanover 4
Indiana 4
Paris 4
Piemonte 4
Pieris 4
San Mateo 4
Tokyo 4
Amsterdam 3
Clearwater 3
Frankfurt am Main 3
Groningen 3
Hanoi 3
Hovelhof 3
Jiaxing 3
Los Angeles 3
Moscow 3
New York 3
Shaoxing 3
Spezzano Albanese 3
São Paulo 3
Taiyuan 3
Udine 3
Venezia 3
Vienna 3
Zagreb 3
Totale 13348
Nome #
SINEUPs are modular antisense long non-coding RNAs that increase synthesis of target proteins in cells 320
Targeted delivery of neutralizing anti-C5 antibody to renal endothelium prevents complement- dependent tissue damage 291
Tissue transglutaminase (TG2) enables survival of human malignant pleural mesothelioma cells in hypoxia 290
Rational design of antirheumatic prodrugs specific for sites of inflammation 286
A non-complement-fixing antibody to  2 glycoprotein I as a novel therapy for antiphospholipid syndrome 217
Testing for Anti-Human Transglutaminase Antibodies in Saliva Is Not Useful for Diagnosis of Celiac Disease 211
Selecting soluble/foldable protein domains through single-gene or genomic ORF filtering: structure of the head domain of Burkholderia pseudomallei antigen BPSL2063 205
Looking for celiac disease: diagnostic accuracy of two rapid commercial assays 177
The gut as site of production of autoimmune antibodies. 173
The Use of Biopsy and "no-Biopsy" Approach for Diagnosing Paediatric Coeliac Disease in the Central European Region 173
Autoantibodies as predictors of disease. 168
Role of anti-osteopontin antibodies in multiple sclerosis and experimental autoimmune encephalomyelitis 167
An Albumin-Derived Peptide Scaffold Capable of Binding and Catalysis 166
null 166
Using archaeal histones for precise DNA fragmentation , 20: 267-271 (2007) 165
Bispecific antibodies targeting tumor-associated antigens and neutralizing complement regulators increase the efficacy of antibody-based immunotherapy in mice. 164
Anti transglutaminase antibodies cause ataxia in mice. 163
null 163
Anti-transglutaminase antibodies and age. 162
SINEUPs: A new class of natural and synthetic antisense long non-coding RNAs that activate translation 160
Analyzing the peripheral blood antibody repertoire of a celiac disease patient using phage antibody libraries 155
Primer sets for cloning the human repertoire of T cell Receptor variable regions 151
Phage display technology for human monoclonal antibodies 150
Construction of miniantibodies for the in vivo study of human autoimmune diseases in animal models 147
Diagnostic Delays in Children with Coeliac Disease in the Central European Region 145
Human recombinant tissue transglutaminase ELISA: an innovative diagnostic assay for celiac disease. 145
Controlling complement resistance in cancer by using human monoclonal antibodies that neutralize complement-regulatory proteins CD55 and CD59 143
One-step cloning of anti tissue transglutaminase scFv from subjects with celiac disease. 143
Recombinant antibody selections by combining phage and yeast display 141
Molecular dissection of the tissue transglutaminase auto-antibody response in celiac disease 139
Dual sugar gut-permeability testing on blood drop in animal models. 137
Development of a novel rapid non-invasive screening test for coeliac disease. 136
Extending filamentous phage host range by the grafting of a heterologous receptor binding domain 134
A reliable screening procedure for coeliac disease in clinical practice. 134
Humoral immune response to tissue transglutaminase is related to epithelial cell proliferation in celiac disease 133
Antibodies in haystacks: how selection strategy influences the outcome of selection from molecular diversity libraries 132
Molecular dissection of the tissue transglutaminase autoantibody response in celiac disease 132
The analysis of the fine specificity of celiac disease antibodies using tissue transglutaminase fragments 132
An Air-well sparging minifermenter system for high-throughput protein production 131
Prevention of arthritis by locally synthesized recombinant antibody neutralizing complement component C5 130
Interactome-Seq: A Protocol for Domainome Library Construction, Validation and Selection by Phage Display and Next Generation Sequencing 130
Gluten ataxia: passive transfer in a mouse model. 127
Profiling the Autoantibody Repertoire by Screening Phage-Displayed Human cDNA Libraries 126
N-glycosylation of the mammalian dipeptidyl aminopeptidase-like protein 10 (DPP10) regulates trafficking and interaction with Kv4 channels 126
Plasmid incompatibility: More compatible than previously thought? 125
Antibodies in proteomics I: generating antibodies 123
Differential induction of IL-17, IL-10, and IL-9 in human T helper cells by B7h and B7.1 122
A definitive set of oligonucleotide primers for amplifying human V regions 122
Mapping the minimum domain of the fibronectin binding site on transglutaminase 2 (TG2) and its importance in mediating signaling, adhesion, and migration in TG2-expressing cells 122
Anti-tissue transglutaminase antibodies activate intracellular tissue transglutaminase by modulating cytosolic Ca2+ homeostasis 120
Mass screening for coeliac disease using antihuman transglutaminase antibody assay. 119
null 119
A label-free immunoassay for Flavivirus detection by the Reflective Phantom Interface technology 119
Majority of children with type 1 diabetes produce and deposit anti-tissue transglutaminase antibodies in the small intestine. 118
Prevalence of celiac disease among risk groups and the general population in USA 117
Impaired glycosylation blocks DPP10 cell surface expression and alters the electrophysiology of i to channel complex 117
Anti-idiotypic response in mice expressing human autoantibodies. 116
Treatment of experimental arthritis by targeting synovial endothelium with a neutralizing recombinant antibody to C5. 116
Antibodies in proteomics II: screening, high-throughput characterization and downstream applications 115
Celiac disease in patients with sporadic and inherited cardiomyopathies and in their relatives. 115
null 114
null 114
In vivo recombination as a tool to generate molecular diversity in phage antibody libraries 113
A Functional Idiotype/Anti-Idiotype Network Is Active in Genetically Gluten-Intolerant Individuals Negative for Both Celiac Disease-Related Intestinal Damage and Serum Autoantibodies 113
Engineering mammalian cell factories with SINEUP noncoding RNAs to improve translation of secreted proteins 113
Filtering "genic" open reading frames from genomic DNA samples for advanced annotation 112
Celiac anti-tissue transglutaminase antibodies interfere with the uptake of alpha gliadin peptide 31-43 but not of peptide 57-68 by epithelial cells 112
Selection and characterization of a novel agonistic human recombinant anti-TRAIL-R2 minibody with anti-leukemic activity. 111
Characterization of the anti-tissue transglutaminase antibody response in nonobese diabetic mice. 109
Rapid and simple dot immunobinding assay to detect anti human transglutaminase antibodies in coeliac disease 107
Cloning and characyerization of intestinal antibodies to tissue transglutaminase in celiac disease patients 107
Profiling celiac disease antibody repertoire 107
RhoB is associated with the anti-angiogenic effects of celiac patient transglutaminase 2-targeted autoantibodies 106
Triggering of B7h by the ICOS modulates maturation and migration of monocyte-derived dendritic cells 106
A Human Monoclonal Antibody Against Domain I Of beta 2-Glycoprotein I prevents Clotting and Fetal Loss Induced By Polyclonal Anti-Phospholipid Antibodies In Animal Models. 106
Transglutaminase 2-specific coeliac disease autoantibodies induce morphological changes and signs of inflammation in the small-bowel mucosa of mice 106
Human tissue transglutaminase ELISA: powerful massscreening diagnostic assay for coeliac disease 105
Recombinant renewable polyclonal antibodies 105
Binders based on dimerised immunoglobulin VH domains 103
Mucosal tissue transglutaminase expression in celiac disease 103
A deep-blue OLED-based biochip for protein microarray fluorescence detection 102
Increasing titres of anti-human-transglutaminase antibodies with age in healthy population 101
Thrombus formation induced by antibodies to beta2-glycoprotein I is complement dependent and requires a priming factor. 101
null 100
A single conformational transglutaminase 2 epitope contributed by three domains is critical for celiac antibody binding and effects 100
Anti-tissue transglutaminase antibodies from coeliac patients inhibit transglutaminase activity both in vitro and in situ. 98
null 97
Protective role of anti-idiotypic network in celiac disease prone subjects 96
The transmembrane β-subunits KCNE1, KCNE2, and DPP6 modify pharmacological effects of the antiarrhythmic agent tedisamil on the transient outward current i to 96
Usefulness of gluten-free diet in gluten-genetically predisposed subjects positive to intestinal mucosa anti-transglutaminase antibodies 95
null 95
Antibodies to transglutaminasefrom phage display libraries 94
Site of syntesis of antibodies to A-gliadin and tissue-transglutaminase in celiac disease patients 93
Usefulness of gluten-free diet in gluten-genetically predisposed subjects positive to intestinal-mucosa anti-transglutaminase antibodies 91
Simple scale-up of recombinant antibody production using an UCOE containing vector 91
Humoral immune responses toward tumor-derived antigens in previously untreated patients with chronic lymphocytic leukemia 91
Characterizing monoclonal antibody epitopes by filtered gene fragment phagedisplay. 88
Celiac anti-type 2 transglutaminase antibodies induce phosphoproteome modification in intestinal epithelial caco-2 cells 87
Antibodies against breain structures in a celiac patient with ataxic syndrome are produced in the intestine 86
Anti-alpha enolase autoantibodies in coeliac disease 86
Totale 13251
Categoria #
all - tutte 28920
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28920


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201831 0000 00 00 00031
2018/20191926 351109156 2443 19102 44230801353
2019/20204064 219201229709 279574 415453 355230268132
2020/20212637 258179261312 204278 147221 144280105248
2021/20221718 8711568139 66157 7555 208180142426
2022/20232675 259335216384 268488 33243 301291190
Totale 17198